期刊文献+

免疫抑制治疗在脓毒血症治疗中的作用 被引量:1

Effects of immunosuppressive therapy on treatment of sepsis
下载PDF
导出
摘要 脓毒血症主要是由异物感染引起的宿主免疫反应失调,进而发展为威胁生命的器官功能障碍。一般认为脓毒血症的发病机制是由最开始的持续性炎症反应中的炎症激活发展为最终的免疫抑制反应中免疫功能缺陷,打破了机体免疫平衡。本文就脓毒血症患者持续过激炎症和免疫抑制动态平衡的重要性及相应治疗进展进行综述。 Sepsis is a disorder of host immune response primarily caused by external infections with further development of life-threatening organ dysfunction.Generally,pathogenesis of sepsis is from initial inflammatory activation in persistent inflammatory response to final immunosuppression of immune function of deficiency,which breaks balance of immune response.This article focuses on signification of dynamic balance between persistent inflammation and immunosuppression in sepsis patients and corresponding treatment progress of sepsis.
作者 廖晓莹 吴迪 吴明江 高艺恬(指导) LIAO Xiaoying;WU Di;WU Mingjiang;GAO Yitian(College of Life and Environmental Sciences,Wenzhou University,Wenzhou 325000,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2023年第1期168-171,共4页 Chinese Journal of Immunology
基金 国家自然科学基金项目(81803345,81803590) 浙江省自然科学基金项目(LY20H310006)。
关键词 脓毒血症 病理机制 持续性炎症反应 免疫抑制 Sepsis Pathological mechanism Persistent inflammation Immunosuppressive
  • 相关文献

参考文献5

二级参考文献80

  • 1董月青,姚咏明.脓毒症中细胞免疫紊乱的机制[J].中国危重病急救医学,2004,16(10):636-638. 被引量:50
  • 2崔乃强,吴咸中.重症急性胰腺炎治疗的现况和展望[J].中国危重病急救医学,2004,16(12):705-707. 被引量:107
  • 3Angus D C, Linde-Zwirble W T, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001, 29 ( 7 ) : 1303- 1310.
  • 4Gogos A, Drosou E, Bassaris H P, et al. Pro-versus anti-inflammatory cytokine profile ih patients with severe sepsis: a marker for prognosis and future therapeutic options[J]. J Infect Dis, 2000, 181 ( 1 ) : 176- 180.
  • 5Hatherill M, Tibby S M, Turner C, et al. Proealcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock[J]. Crit Care Med, 2000, 28 ( 7 ) : 2591-2594.
  • 6Eskandari M K, Bolgos G, Miller C, et al. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J]. J Immunol, 1992, 148 (9) : 2724- 2730.
  • 7Echtenaeher B, Weigl K, Lehn N, et al. Tumor necrosis factor- dependent adhesions as a major protective mechanism early in septic peritonitis in mice[J]. Infect Immun, 2001, 69 ( 6 ) : 3550-3555.
  • 8Ruffell A J. The utilization of continuous veno-venous hemofiltration for the removal of septic mediators in patients with systemic inflammatory response syndrome[J]. Intensive Crit Care Nuts, 2003, 19 (4) : 207-214.
  • 9Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration[J]. Kidney Blood Press Res, 2003, 26 (2) : 128-134.
  • 10Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients[J]. Nephrol Dial Transplant, 2001, 16 ( 5 ) : 67-72.

共引文献89

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部